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Sir,
The causal nature of the association between formaldehyde 
exposure and risk of leukemia reported in some epidemiology 
studies (see (1) for review) has been questioned by the results 
of recent original studies and re-analyses, including some pub-
lished by us (2–4).
A number of articles published in Carcinogenesis (5–7) and 
elsewhere (8–10), that reported the results of analyses of data 
derived from a cross-sectional study of hematologic and cytoge-
netic biomarkers (11), have been used to support a causal inter-
pretation of the findings of some of the epidemiology studies. 
Although these articles pose and discuss interesting hypothe-
ses, it is not clear that the data, as obtained and reported, validly 
support the conclusions of the authors (9,10,12).
The failure of the original study authors to adhere to the pro-
tocol of counting a minimum number of 150 cells in establish-
ing the prevalence of cytogenetic abnormalities is a potentially 
important problem (9,13). In the Lan et  al. study (5), the pres-
entation of the data related to prevalence of monosomy 7 and 
trisomy 8 does not allow the reader to determine the number 
of cells that were counted, and the studies by Seow et al. (6) and 
Bassig et al. (7) relied upon the same results.
Another potential problem is that the original study and 
subsequent analyses were ‘ecological’: exposure and biomarker 
data were compared at the group (i.e. ‘exposed’ versus ‘unex-
posed’) level, precluding any valid representation that observed 
associations reflect any dose–response relationship or even 
change from a lower to higher level due to exposure (9,10). By 
referring to the cross-sectional prevalence of indicators in 
terms of ‘changes’, even the title of one of the original studies 
(‘Occupational exposure to formaldehyde, hematotoxicity, and 
leukemia-specific chromosome changes in cultured myeloid 
progenitor cells’ (11)) suggests a methodology that actually 
might document the movement of individual study outcome 
measures in response to an exposure event.
In addition, despite the overlapping data used across the 
three studies, some are described as confirmatory: ‘Our current 
findings confirm our earlier findings that formaldehyde expo-
sure was associated with aneuploidy in cultured circulating 
myeloid progenitor cells in vivo’ (5). The current findings are, at 
least in part, the earlier findings, as the samples used for the 
aneuploidy analysis were likely from some of the same workers.
Furthermore, Gentry et al. (9). noted that although collected 
and described in Zhang et al. (11), individual formaldehyde expo-
sure data were not used in these analyses. Mundt et al. obtained 
the formaldehyde exposure data for each exposed worker from 
this study, and performed extended analyses that demonstrated 
no exposure relationship for any of the haematological or 
cytogenetic markers, specifically monosomy 7 or trisomy 8 (10).
The analyses by Mundt et al. (10) of the original Zhang et al. 
(11) data were the first to present results by actual exposure 
data and draw into question some of the interpretations offered 
by the original authors (5–7,11). Lan et al. argued that an expo-
sure-response analysis could not be conducted because of the 
narrow range of exposure (5). In fact, the 10th–90th percentile 
of the distribution of formaldehyde exposure concentration 
ranged between 0.8 and 2.5 ppm, a threefold range above the US 
Occupational Safety and Health Administration (OSHA) permis-
sible exposure limit (PEL) of 0.75 ppm (10).
We appreciate the efforts of many colleagues contributing 
to identify potential biological mechanisms by which exoge-
nous formaldehyde exposure might be related to leukemia risk. 
However, the underlying data and statistical analyses appear 
not to meet basic methodological standards. Alternative expla-
nations for associations seen between the combined groups 
of exposed and unexposed workers—but not across measured 
exposure concentrations—have never been explored. The ques-
tionable inferential value of the monosomy 7 and trisomy 8 
prevalence findings based on methods deviating from proto-
col also needs to be addressed. Replication of these results in 
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high-quality studies conducted in independent populations is 
needed before conclusions can be drawn on putative mecha-
nisms of formaldehyde-induced leukaemia in exposed humans.
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